Related to Affymetrix, Leica Forge Pact for Single-Copy RNA ISH Tissue Assay for Research Use

• Gamma Partners with Health Diagnostic Lab to Develop Risk Assay for Heart Attack and Stroke
  
• FDA Grants 510(k) Approval to OraSure and Roche for Drug-of-Abuse Assays
  
• Integrated DNA Technologies to Custom Manufacture Quanta Biosciences' miRNA Assays
  
• Morphotek and Biocare Partner to Develop mAb-Based Assay for Cancer Antigen
  
• Optivia Wins $1.85M Phase II Grant to Develop Drug-Drug Interaction Assays
  
• Researchers Claim That Measuring Seven Proteins Could Help Anticipate Melanoma Relapse
  
• BD Diagnostics Taps Diagenode to Develop Seven IVDs for BD Max System
  
• Investigators Pour Doubt on Accepted Understanding of DNA-to-RNA Sequence Equivalence
  
• Abcam Completes $6M Takeover of Mitochondrial Research Tools Specialist MitoSciences
  
• DxTerity Acquires Cancer Gene Expression Assay IP from SourceMDx
  
• Merck KGaA to Use MDxHealth’s Assay in Second Clinical Glioblastoma Study
  
• FDA Grants 510(k) Clearance for Mitsubishi’s Pathfast Cardiac Troponin I Assay
  
• Metamark and Definiens Partner to Develop Tissue-Based Cancer Diagnostics
  
• Proteome Sciences and Moffitt Cancer Center Ally on Mass Spec-Based Clinical Assays
  
• BioFocus Collaborates with Michael J. Fox Foundation on Parkinson Disease Diagnostic
  
• Proteome Sciences and Buck Institute Ally on MS-Based Anti-Estrogen Therapy Resistance Assays
  
• Researchers Develop Spectrum of Fluorescent Tags for Monitoring RNA Production and Movement
  
• BD Partners with Lab21 to Develop Aspergillus Assay for BD MAX Real-Time PCR Platform
  
• BD Diagnostics and Biodiversity Join Forces to Develop Assays for BD Max System
  
• Lumora Partners with 3M to Develop Bioluminescent Reporter Platform for Molecular Diagnostics